Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium nitrate is an inorganic salt used both as a therapeutic agent and a dietary supplement. In cardiovascular research, it acts as a precursor to nitric oxide (NO) via the enterosalivary nitrate–nitrite–NO pathway. By increasing NO bioavailability, it is intended to promote vasodilation and improve mitochondrial efficiency, particularly in patients with Heart Failure with Preserved Ejection Fraction (HFpEF). While acute studies initially showed promise for improving exercise duration, larger chronic trials, such as the KNO3CK OUT HFpEF study, have failed to demonstrate significant improvements in aerobic capacity or quality of life. In dentistry, potassium nitrate is a widely used desensitizing agent in toothpastes. It works by increasing extracellular potassium ion concentration around sensory nerve endings in the dentin, leading to depolarization and inhibiting the transmission of pain signals associated with dentin hypersensitivity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium nitrate.